Pharmaceutics

Pharmaceutics

药剂学

  • 3区 中科院分区
  • Q1 JCR分区

期刊简介

《Pharmaceutics》是由MDPI (Basel, Switzerland)出版社于2009年创办的英文国际期刊(ISSN: 1999-4923,E-ISSN: 1999-4923),该期刊长期致力于药学领域的创新研究,主要研究方向为Pharmacology, Toxicology and Pharmaceutics-Pharmaceutical Science。作为SCIE收录期刊(JCR分区 Q1,中科院 3区),本刊采用OA开放获取模式(OA占比1%),以发表药学领域等方向的原创性研究为核心(研究类文章占比70.06%%)。凭借严格的同行评审与高效编辑流程,期刊年载文量精选控制在2749篇,确保学术质量与前沿性。成果覆盖Web of Science、Scopus等国际权威数据库,为学者提供推动医学领域高水平交流平台。

投稿咨询

投稿提示

Pharmaceutics审稿周期约为约16.41天 11 Weeks 。该刊近年未被列入国际预警名单,年发文量约2749篇,录用竞争适中,主题需确保紧密契合医学前沿。投稿策略提示:避开学术会议旺季投稿以缩短周期,语言建议专业润色提升可读性。

  • 医学 大类学科
  • English 出版语言
  • 是否预警
  • SCIE 期刊收录
  • 2749 发文量

中科院分区

中科院 SCI 期刊分区 2023年12月升级版

Top期刊 综述期刊 大类学科 小类学科
医学
3区
PHARMACOLOGY & PHARMACY 药学
2区

中科院 SCI 期刊分区 2022年12月升级版

Top期刊 综述期刊 大类学科 小类学科
医学
2区
PHARMACOLOGY & PHARMACY 药学
2区

JCR分区

按JIF指标学科分区 收录子集 分区 排名 百分位
学科:PHARMACOLOGY & PHARMACY SCIE Q1 45 / 354

87.4%

按JCI指标学科分区 收录子集 分区 排名 百分位
学科:PHARMACOLOGY & PHARMACY SCIE Q1 42 / 354

88.28%

CiteScore

CiteScore SJR SNIP CiteScore 排名
CiteScore:7.9 SJR:0.892 SNIP:1.005
学科类别 分区 排名 百分位
大类:Pharmacology, Toxicology and Pharmaceutics 小类:Pharmaceutical Science Q1 32 / 183

82%

期刊发文

  • A Cationic Amphiphilic AIE Polymer for Mitochondrial Targeting and Imaging

    Author: Zhou, Junliang; Wang, Haiyang; Wang, Wen; Ma, Zhiwei; Chi, Zhenguo; Liu, Siwei

    Journal: PHARMACEUTICS. 2023; Vol. 15, Issue 1, pp. -. DOI: 10.3390/pharmaceutics15010103

  • Synergistic Pro-Apoptotic Effect of a Cyclic RGD Peptide-Conjugated Magnetic Mesoporous Therapeutic Nanosystem on Hepatocellular Carcinoma HepG2 Cells

    Author: Zhao, Xuanping; Liu, Chuan; Wang, Zichao; Zhao, Yingyuan; Chen, Xuyang; Tao, Haizhen; Chen, Hong; Wang, Xueqin; Duan, Shaofeng

    Journal: PHARMACEUTICS. 2023; Vol. 15, Issue 1, pp. -. DOI: 10.3390/pharmaceutics15010276

  • Current Progress and Outlook of Nano-Based Hydrogel Dressings for Wound Healing

    Author: Zhang, Xiao; Wei, Pengyu; Yang, Zhengyang; Liu, Yishan; Yang, Kairui; Cheng, Yuhao; Yao, Hongwei; Zhang, Zhongtao

    Journal: PHARMACEUTICS. 2023; Vol. 15, Issue 1, pp. -. DOI: 10.3390/pharmaceutics15010068

  • Pharmacokinetic/Pharmacodynamic Evaluation of Aztreonam/Amoxicillin/Clavulanate Combination against New Delhi Metallo-beta-Lactamase and Serine-beta-Lactamase Co-Producing Escherichia coli and Klebsiella pneumoniae

    Author: Zhang, Jiayuan; Wu, Mengyuan; Diao, Shuo; Zhu, Shixing; Song, Chu; Yue, Jiali; Martins, Frederico S.; Zhu, Peijuan; Lv, Zhihua; Zhu, Yuanqi; Yu, Mingming; Sy, Sherwin K. B.

    Journal: PHARMACEUTICS. 2023; Vol. 15, Issue 1, pp. -. DOI: 10.3390/pharmaceutics15010251

  • Novel Development of Nanoparticles-A Promising Direction for Precise Tumor Management

    Author: Zhang, Dengke; Tang, Qingqing; Chen, Juan; Wei, Yanghui; Chen, Jiawei

    Journal: PHARMACEUTICS. 2023; Vol. 15, Issue 1, pp. -. DOI: 10.3390/pharmaceutics15010024

  • Functional Hydrogels and Their Applications in Craniomaxillofacial Bone Regeneration

    Author: Yu, Yi; Yu, Tingting; Wang, Xing; Liu, Dawei

    Journal: PHARMACEUTICS. 2023; Vol. 15, Issue 1, pp. -. DOI: 10.3390/pharmaceutics15010150

  • Advances in the Application of Preclinical Models in Photodynamic Therapy for Tumor: A Narrative Review

    Author: Yu, Rong; Maswikiti, Ewetse Paul; Yu, Yang; Gao, Lei; Ma, Chenhui; Ma, Huanhuan; Deng, Xiaobo; Wang, Na; Wang, Bofang; Chen, Hao

    Journal: PHARMACEUTICS. 2023; Vol. 15, Issue 1, pp. -. DOI: 10.3390/pharmaceutics15010197

  • The Progress of Chitosan-Based Nanoparticles for Intravesical Bladder Cancer Treatment

    Author: Yu, Chong; Wang, Shuai; Lai, Wing-Fu; Zhang, Dahong

    Journal: PHARMACEUTICS. 2023; Vol. 15, Issue 1, pp. -. DOI: 10.3390/pharmaceutics15010211